Back
Cepheid’s Solutions
Back
Testing Everywhere
Back
Customer Support
Back
Self-Service Support
Back
Safety Data Sheets
Back
IVDR Update
Back
Specimen Collection
Back
Contact Us
Back
About Cepheid
Back
Mission and History
Back
Our Leadership
Back
Distributors
Back
News
Back
Events
Back
Careers
Xpert® MRSA/SA BC (10-test kit)
GXMRSA/SABC-CE-10
Unit price
Subtotal
Product is not available for purchase in your region.
Total
({{currency}})
0
MSDS/SDS
eng
MSDS/SDS
eng
GXNOV-CE-10
Fast detection of Norovirus GI & GII with results available in 90 minutes
GXCARBARP-CE-10|GXCARBAR-CE-10
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 50 minutes
GXMRSA/SA-SSTI-CE
Detect MRSA & SA Skin and Soft Tissue Infections in 62 minutes
1. What is the Xpert® MRSA/SA Blood Culture test?
1. What is the Xpert® MRSA/SA Blood Culture test?
The Xpert® MRSA/SA Blood Culture test, performed on the GeneXpert® systems, is a qualitative in vitro diagnostic test intended for the detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA directly from positive blood cultures.1
2. How does the Xpert® MRSA/SA Blood Culture test work?
2. How does the Xpert® MRSA/SA Blood Culture test work?
The test utilizes automated real-time polymerase chain reaction (PCR) for the amplification of MRSA/SA specific DNA targets and fluorogenic target-specific hybridization probes for the real-time detection of the amplified DNA.1
3. What is the indicated use for the Xpert MRSA/SA Blood Culture test?
3. What is the indicated use for the Xpert MRSA/SA Blood Culture test?
The Xpert MRSA/SA Blood Culture test is indicated for use in conjunction with other laboratory tests, such as culture, and clinical data available to the clinician as an aid in the detection of MRSA/SA from positive blood cultures. Subculturing of positive blood cultures is necessary to recover organisms for susceptibility testing or for epidemiological typing. The Cepheid Xpert MRSA/SA Blood Culture test is not intended to monitor treatment for MRSA/SA infections.1
4. What is Staphylococcus aureus (SA) and MRSA?
4. What is Staphylococcus aureus (SA) and MRSA?
Staphylococcus aureus (SA) is a human pathogen, which is the causative agent of a range of diseases including bacteremia, endocarditis, osteomyelitis, toxic shock syndrome, food poisoning, carbuncles, and boils.1
In the early 1950s, acquisition and spread of beta-lactamase-producing plasmids thwarted the effectiveness of penicillin for treating SA infections. In 1959, methicillin, a semi-synthetic penicillin, was introduced and, soon after, methicillin-resistant SA (MRSA) strains were identified.1
5. How does being colonized with MRSA impact the likelihood of developing MRSA infections?
5. How does being colonized with MRSA impact the likelihood of developing MRSA infections?
MRSA colonization increases the risk of infection, with infecting strains match colonizing strains in as many as 50–80% of cases. MRSA nasal colonization rates range from 0.9% to 1.5% in the United States2
References:
1. Xpert® MRSA/SA Blood Culture Package Insert. Accessed 9/25/2024. https://www.cepheid.com/en-EEntent/dam/www-cepheid-com/documents/package-insert-files/301-1061-mrsa-sa-bc/IFU%20MRSA.SA%20BC%20ENGLISH%20301-1061%20Rev%20F.pdf
2. Turner, N.A., Sharma-Kuinkel, B.K., Maskarinec, S.A. et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol 17, 203–218 (2019). https://doi.org/10.1038/s41579-018-0147-4
View our additional portals to find documents and resources not listed here.
View our self-help articles, create a case, or view contact information.
